Cellular immunotherapy targets a common human cancer mutation

In a study of an immune therapy for colorectal cancer that involved a single patient, a team of researchers at the National Cancer Institute (NCI) identified a method for targeting the cancer-causing protein produced by a mutant form of the KRAS gene.

Read more

Immunotherapy fights cancer better with both arms of the immune system, say researchers

Immunotherapy – the enlisting of the immune system to fight cancer – is an exciting new field that has already led to early trials of new treatments. However, these often fail because promising results seen in petri dishes are not translating into successful attacks on real tumors. Read more